Association of Repeated Blood Cultures With Mortality in Adult Patients With Gram-Negative Bacilli Bacteremia: A Systematic Review and Meta-analysis

Abstract Background Performing repeat blood cultures after an initial positive culture (ie, follow-up blood cultures [FUBCs]) in patients with gram-negative bacilli (GNB) bacteremia is controversial. We aimed to comprehensively review the association of FUBCs with improvement in patient-relevant clinical outcomes in GNB bacteremia. Methods We performed a systematic review and random-effects meta-analysis to calculate summary effect estimates. We used hazard ratios as the effect measure. The primary outcome was 30-day or in-hospital mortality, and secondary outcomes were length of treatment and length of hospital stay. We searched PubMed, Embase, and Cochrane Central Register of Controlled Trials (Central) without language restrictions from inception to April 29, 2022. Original clinical studies evaluating the association between FUBCs and mortality in adult patients with GNB bacteremia were included. FUBC details were reviewed. Two independent reviewers used the Risk of Bias in Non-randomised Studies of Interventions tool. Results We identified 9 eligible retrospective studies. In total, 7778 hospitalized patients with GNB bacteremia were included. The studies were clinically heterogeneous and had a critical risk of bias. The utilization of FUBCs varied across studies (18%–89%). Random-effects meta-analysis of covariate-adjusted estimates found that FUBC use was associated with reduced mortality. Although not a result of the meta-analysis, lengths of treatment and hospital stay were longer for patients with FUBCs than for those without. Adverse events were not reported. Conclusions FUBC acquisition was associated with lower mortality and longer hospital stay and treatment duration in GNB bacteremia. The risk of bias was critical, and no firm data were available to support mechanisms.

[1]  J. Thaden,et al.  Association of Follow-up Blood Cultures With Mortality in Patients With Gram-Negative Bloodstream Infections , 2022, JAMA network open.

[2]  T. Kuno,et al.  Association between follow-up blood cultures for gram-negative bacilli bacteremia and length of hospital stay and duration of antibiotic treatment: A propensity score-matched cohort study , 2022, Infection Control & Hospital Epidemiology.

[3]  L. Pineles,et al.  Follow-up blood cultures in Pseudomonas aeruginosa bacteremia: A potential target for diagnostic stewardship , 2021, Antimicrobial Stewardship & Healthcare Epidemiology.

[4]  P. Bookstaver,et al.  Impact of follow up blood cultures on outcomes of patients with community-onset gram-negative bloodstream infection , 2021, EClinicalMedicine.

[5]  E. Mayo-Wilson,et al.  The PRISMA 2020 statement: an updated guideline for reporting systematic reviews , 2021, BMJ.

[6]  Kabir Yadav,et al.  Immortal Time Bias in Observational Studies. , 2021, JAMA.

[7]  J. Lynch,et al.  Follow-up blood cultures in E. coli and Klebsiella spp. bacteremia—opportunities for diagnostic and antimicrobial stewardship , 2021, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology.

[8]  Guido Knapp,et al.  Interval estimation of the overall treatment effect in random‐effects meta‐analyses: Recommendations from a simulation study comparing frequentist, Bayesian, and bootstrap methods , 2020, Research synthesis methods.

[9]  M. Venditti,et al.  Are Follow-Up Blood Cultures Useful in the Antimicrobial Management of Gram Negative Bacteremia? A Reappraisal of Their Role Based on Current Knowledge , 2020, Antibiotics.

[10]  R. Jagarlamudi,et al.  Follow-up Blood Cultures in Gram-negative Bacteremia: How Do They Impact Outcomes? , 2020, Journal of community hospital internal medicine perspectives.

[11]  P. G. Choe,et al.  Predictive scoring models for persistent gram-negative bacteremia that reduce the need for follow-up blood cultures: a retrospective observational cohort study , 2020, BMC Infectious Diseases.

[12]  Suril S. Mehta,et al.  Challenges and recommendations on the conduct of systematic reviews of observational epidemiologic studies in environmental and occupational health , 2020, Journal of Exposure Science & Environmental Epidemiology.

[13]  N. Daneman,et al.  The culture of follow up blood cultures. , 2020, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[14]  J. Thaden,et al.  Positive follow-up blood cultures identify high mortality risk Among patients with gram negative bacteremia. , 2020, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[15]  S. Ambretti,et al.  Follow-up blood cultures are associated with improved outcome of patients with gram-negative bloodstream infections: retrospective observational cohort study. , 2020, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[16]  S. Cosgrove,et al.  Does This Patient Need Blood Cultures? A Scoping Review of Indications for Blood Cultures in Adult Non-Neutropenic Inpatients. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  M. Tungsiripat.  Follow-up blood cultures are often needed after bacteremia , 2019, Cleveland Clinic journal of medicine.

[18]  G. Collins,et al.  Handling time varying confounding in observational research , 2017, British Medical Journal.

[19]  M. Hernán,et al.  ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions , 2016, British Medical Journal.

[20]  James M Robins,et al.  Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available. , 2016, American journal of epidemiology.

[21]  J. Sobel,et al.  Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  W. Xiong,et al.  Sending repeat cultures: is there a role in the management of bacteremic episodes? (SCRIBE study) , 2015, BMC Infectious Diseases.

[23]  M. Al-Hasan,et al.  Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe. , 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[24]  J. Ioannidis,et al.  Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials , 2011, BMJ : British Medical Journal.

[25]  Richard D Riley,et al.  Interpretation of random effects meta-analyses , 2011, BMJ : British Medical Journal.

[26]  David J Spiegelhalter,et al.  A re-evaluation of random-effects meta-analysis , 2009, Journal of the Royal Statistical Society. Series A,.

[27]  Sung-Han Kim,et al.  Bloodstream Infections Caused by Antibiotic-Resistant Gram-Negative Bacilli: Risk Factors for Mortality and Impact of Inappropriate Initial Antimicrobial Therapy on Outcome , 2004, Antimicrobial Agents and Chemotherapy.

[28]  K. Chapin,et al.  Epidemiology and Outcome of Nosocomial and Community-Onset Bloodstream Infection , 2003, Journal of Clinical Microbiology.

[29]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[30]  Sara E Cosgrove,et al.  Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  M. Graffar.  [Modern epidemiology]. , 1971, Bruxelles medical.